The company
SpyGlass Pharma, Inc.
SGP · Nasdaq
We hold no 150-day reading for SGP yet: it needs about 200 sessions of history. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- not in the set
- Weeks in an uptrend
- —
- Industry in uptrend
- 27% -9 in 4 wk
- Insider buys, 12 months
- $443.0M
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 51 (+18)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 0 of 0 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Vensana Capital I Gp, Llc10% owner | bought | 165,000at $16.00 | 9 Feb 2026filed 10 Feb 2026 |
| Kirk G. NielsenDirector | bought | 165,000at $16.00 | 9 Feb 2026filed 10 Feb 2026 |
| Paul Edward Walker10% owner | bought | 937,500at $16.00 | 9 Feb 2026filed 11 Feb 2026 |
| Carmen Chang10% owner | bought | 937,500at $16.00 | 9 Feb 2026filed 11 Feb 2026 |
| Edward T. Mathers10% owner | bought | 937,500at $16.00 | 9 Feb 2026filed 11 Feb 2026 |
| Scott D. Sandell10% owner | bought | 937,500at $16.00 | 9 Feb 2026filed 11 Feb 2026 |
| Mohamad Makhzoumi10% owner | bought | 937,500at $16.00 | 9 Feb 2026filed 11 Feb 2026 |
| Rick Yang10% owner | bought | 937,500at $16.00 | 9 Feb 2026filed 11 Feb 2026 |
| New Enterprise Associates 17, L.p.10% owner | bought | 937,500at $16.00 | 9 Feb 2026filed 11 Feb 2026 |
| Forest Baskett10% owner | bought | 937,500at $16.00 | 9 Feb 2026filed 11 Feb 2026 |
| Anthony A. Florence, Jr.10% owner | bought | 937,500at $16.00 | 9 Feb 2026filed 11 Feb 2026 |
| Ali BehbahaniDirector, 10% owner | bought | 937,500at $16.00 | 9 Feb 2026filed 11 Feb 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| RA CAPITAL MANAGEMENT, L.P.unchanged · filed 14 Aug 2026 | 8,021,117$178.6M | 00.0% |
| NEA Management Company, LLCunchanged · filed 14 Aug 2026 | 7,392,301$164.6M | 00.0% |
| Sands Capital Alternatives, LLCunchanged · filed 13 Aug 2026 | 2,500,012$55.7M | 00.0% |
| SAMSARA BIOCAPITAL, LLCunchanged · filed 14 Aug 2026 | 2,109,953$47.0M | 00.0% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 711,712$15.8M | +566,973+391.7% |
| Vestal Point Capital, LPadded · filed 14 Aug 2026 | 670,000$14.9M | +3,240+0.5% |
| JPMORGAN CHASE & COnew · filed 12 Aug 2026 | 629,739$13.6M | +629,739 |
| DEERFIELD MANAGEMENT COMPANY, L.P.unchanged · filed 14 Aug 2026 | 550,000$12.2M | 00.0% |
| MILLENNIUM MANAGEMENT LLCadded · filed 14 Aug 2026 | 507,257$11.3M | +38,463+8.2% |
| Aberdeen Group plcadded · filed 31 Jul 2026 | 493,076$11.0M | +272,622+123.7% |
News
Everyone who traded it
Same industry
No other stock in its industry this week.
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.